Managed Healthcare Executive February 29, 2024
AMCP CEO Susan Cantrell spoke with Managed Healthcare Executive about the challenges of pinpointing specific causes for high drug prices.
Cantrell emphasized the crucial role of innovation in driving prescription drug costs, sharing the exciting advancements in therapies for long-standing health issues. However, she did caution against some policy solutions that might intervene in any innovations.
Additionally, she stressed the importance of payment models, supporting the Medicaid Value-Based Payments for Patients (MVP) Act to enhance Medicaid patients’ access to high-cost therapies.
...